Aarti Pharmalabs Limited has confirmed the status of share dematerialization requests for the quarter ended March 31, 2026. Following due verification by its Registrar and Share Transfer Agent, MUFG Intime India Private Limited, the company announced that there were no dematerialization requests received from shareholders during this period. This update ensures transparency regarding the company’s share registry and compliance processes.
Quarterly Dematerialization Report
Aarti Pharmalabs Limited has released its compliance update regarding the processing of share certificates for the quarter concluding March 31, 2026. The report, issued by the company’s Registrar and Share Transfer Agent, confirms that the firm successfully managed all registry-related activities for the period.
Processing Status
During the January-March 2026 quarter, the company did not receive any requests from shareholders for the dematerialization of shares. As a result, there were no share certificates required to be mutilated or cancelled, and no changes were necessitated in the register of members for this specific quarter. The company remains committed to maintaining accurate shareholder records and ensuring the smooth functioning of its depository participant operations.
Source: BSE
